2010 Health Economics Publications
Publications of health economists currently based within the Sydney School of Public Health.
Peer Reviewed Journal Articles:
Arendts G and Howard K The interface between residential aged care and the emergency department: a systematic review. Age and Ageing, 2010; 39(3), 306-12.
Clarke PM. and Fitzgerald E. “How can the expiry of patent protection on statins impact on pharmaceutical expenditure in Australia?”, Medical Journal of Australia, available early online: click here
Clarke P.M. Glasziou P. Patel A. Chalmers J. Woodward M. Harrap SB. and Salomon JA. “Event rates, hospital utilization and costs associated with major complications of diabetes: multi-country comparative analysis” PLOS Medicine, 7(2): e1000236. doi:10.1371/journal.pmed.1000236
Clarke P. and Van Ourti, T. "Correcting the Bias in the Concentration Index when Income is Grouped,", Journal of Health Economics, 2010 29 (1) 010: 151-157.
Cunich, M and Whelan S 2010 Forthcoming 'Nurse Education and the Retention of Registered Nurses in New South Wales', The Economic Record 2010;86(274):396-413
Glasziou P. Clarke P. Alexander J. Rajmokan M. Beller E. Woodward M. Poulter N. Chalmers J. Patel A. “Cost-effectiveness of blood pressure lowering with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis” Medical Journal of Australia, in press (accepted June 2010).
Howard K, White S, Salkeld G, McDonald S, Craig J, Chadban S, Cass A. Cost-effectiveness of screening and optimal management for diabetes, hypertension and chronic kidney disease to prevent end-stage kidney disease: a modelled analysis. Value in Health, 2010; 13(2): 196-208. (IF 3.009, B).
Islam M.K, Gerdtham, U.G., Clarke, P. Burström K. “Does income-related health inequality change as the population ages? Evidence from Swedish panel data”, Health Economics , 2010 19 (3): 334 – 349
Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B. Estimates of overdetection of invasive breast cancer due to screening mammography. Cancer Causes and Control 2010; 21(2): 275-282. (DOI 10.1007/s10552-009-9459-z)
Morton RL, Howard K, Webster AC, Snelling P. Patient INformation about Options for Treatment (PINOT): methods of a national audit of information provision in chronic kidney disease. Nephrology. 2010; In press
Morton R.L., Tong A, Howard, K., Snelling P, Webster A. "The views of patients and carers in treatment decision making for chronic kidney disease: a systematic review and thematic synthesis of qualitative studies." BMJ. 2010;340:c112
Morton, R.L., Devitt J, Howard K, Anderson K, Snelling P, Cass A. "Patient Views About Treatment of Stage 5 CKD: A Qualitative Analysis of Semistructured Interviews." Am J Kidney Dis. 2010
doi:10.1053/j.ajkd.2009.11.011
Morton RL, Howard K, Webster AC, Snelling P. Patient INformation about Options for Treatment (PINOT): A prospective national study of information given to incident CKD Stage 5 patients. Nephrol Dial Transplant. Accepted Aug 2010
Price, H C. Clarke, P M. Gray, A M. and Holman R R. “Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities” Med Decis Making first published on December 30, 2009 as doi:10.1177/0272989X09349960
Robotin MC, Kansil MQ, George J, Howard K, Tipper S, Levy M, Phung N, Penman AG. Using a population-based approach to prevent hepatocellular cancer New South Wales, Australia: effects on health service utilisation BMC Health Services Research 2010, 10:215
Tong A, Howard K, Jan S, Cass A, Rose J, Chadban S, Allen RD, Craig JC. Community preferences for the allocation of solid organs for transplantation: a systematic review. Transplantation 2010; 89(7): 796-805.
Tong, A., Morton, R.L., Howard, K., McTaggart, S., and Craig, J.C., “When I had my transplant, I became normal.” Adolescent perspectives on life after kidney transplantation. Pediatric Transplantation. Accepted Nov 2010.
Wong G, Howard K, Craig JC. Economic evaluation in clinical nephrology: Part 2. Applying economic evaluations in clinical nephrology. Nephrology (Carlton), 2010; 15(5): 533-9.
Wong G, Howard K, Craig JC. Economic evaluation in clinical nephrology: Part 2. Applying economic evaluations in clinical nephrology. Nephrology (Carlton), 2010; 15(5): 533-9.
Wong G, Howard K, Webster AC, Chapman JR, Craig JC. Screening for renal cancer in recipients of kidney transplants, Nephrology Dialysis Transplantation, 2010 doi: 10.1093/ndt/gfq627
Books:
Clarke PM “Methods for evaluating health and health care – underlying theory and implications for practical application” in McIntosh E, Clarke PM, Frew E and Louviere J (Eds). Applied methods of cost-benefit analysis in health care, Oxford University Press (In press)
Clarke PM “Using revealed preference methods to value health care – The Travel Cost Approach” in McIntosh E, Clarke PM, Frew E and Louviere J. (Eds) Applied methods of cost-benefit analysis in health care, Oxford University Press: Oxford (In press)
Gray A. Clarke P. Wolstenholme J. Wordsworth S. Applied Methods of cost-effectiveness analysis, Oxford University Press: Oxford (In Press Publication Date Expect Nov 2010)
Letters:
Clarke, P.M., and FitzGerald E.M., "Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia" Med J Aust 2010; 193 (3): 186-187.
Morton, R.L., Howard, K, Thompson JF. In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma Annals of Surgical Oncology (2010) DOI 10.1245/s10434-009-0823-8